epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Inpefa

sotagliflozin

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 200 mg, 400 mg

heart failure-associated risk reduction

[patients with heart failure]
Dose: 200-400 mg PO qd; Start: 200 mg PO qd, then may incr. dose to 400 mg PO qd after at least 2wk; Info: start tx when hemodynamically stable in patients with decompensated heart failure; give <1h before first meal of the day; do not cut/crush/chew tab; consider holding tx at least 3 days before surgery
[patients with diabetes mellitus type 2, CKD, or other cardiovascular risk factors]
Dose: 200-400 mg PO qd; Start: 200 mg PO qd, then may incr. dose to 400 mg PO qd after at least 2wk; Info: give <1h before first meal of the day; do not cut/crush/chew tab; consider holding tx at least 3 days before surgery

renal dosing

[see below]
eGFR >90: no adjustment; eGFR 25-90: not defined, caution advised; eGFR <25: not defined
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class B or C: avoid use

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@4e8e39a5
  • hypersensitivity to drug or ingredient
  • hepatic impairment, Child-Pugh Class B-C
  • pregnancy 2nd trimester
  • pregnancy 3rd trimester
  • breastfeeding
  • volume depletion
  • diabetic ketoacidosis
  • caution: elderly patients
  • caution: renal impairment
  • caution: pregnancy 1st trimester
  • caution: hypotension
  • caution: ketoacidosis risk
  • caution: pancreatic insulin deficiency
  • caution: fasting, prolonged
  • caution: alcohol abuse
  • caution: genital mycotic infection history

Drug Interactions .

Overview

sotagliflozin

SGLT1/SGLT2 inhibitor

Interaction Characteristics:
  • UGT1A9 substrate
  • P-gp inhibitor, weak
  • fluid/electrolyte loss
  • hypoglycemic effects
  • hypotensive effects

Contraindicated

  • colchicine
  • Inpefa (sotagliflozin)
    +
    colchicine
    1 interaction

    Contraindicated

    sotagliflozin + colchicine

    CV RISK REDUCTION: consider monitoring CK, myopathy s/sx; GOUT OR FMF: contraindicated in pts w/ renal or hepatic impairment; otherwise, consider decr. colchicine dose during and x14 days after sotagliflozin use: combo may incr. colchicine levels, risk of myopathy, rhabdomyolysis, other life-threatening toxicity (P-gp-mediated transport inhibited)

Avoid/Use Alternative

  • aldesleukin
  • Inpefa (sotagliflozin)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • apixaban
  • Inpefa (sotagliflozin)
    +
    apixaban
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + apixaban

    ADULT PTS: monitor bleeding s/sx; if also combined w/ strong CYP3A4 inhibitor, decr. apixaban 5mg bid or 10 mg bid dose by 50% or avoid combo if already on 2.5 mg bid; PEDS PTS: monitor bleeding s/sx; if also combined w/ strong CYP3A4 inhibitor, consider decr. apixaban dose: combo may incr. apixaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • bexagliflozin
  • Inpefa (sotagliflozin)
    +
    bexagliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + bexagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • canagliflozin
  • Inpefa (sotagliflozin)
    +
    canagliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + canagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • dabigatran
  • Inpefa (sotagliflozin)
    +
    dabigatran
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + dabigatran

    ATRIAL FIBRILLATION: avoid combo if CrCl <30 mL/min; OTHER INDICATIONS: avoid combo if CrCl <50 mL/min; if dabigatran use for DVT/PE prophylaxis post-hip replacement and CrCl >50 mL/min, consider separating admin. at least 2h apart: combo may incr. dabigatran levels, risk of bleeding (including life-threatening), other adverse effects (P-gp-mediated transport inhibited)

  • dapagliflozin
  • Inpefa (sotagliflozin)
    +
    dapagliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + dapagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • empagliflozin
  • Inpefa (sotagliflozin)
    +
    empagliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + empagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • ensartinib
  • Inpefa (sotagliflozin)
    +
    ensartinib
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + ensartinib

    avoid combo: combo may incr. ensartinib levels, risk of bradycardia, hyperglycemia, other adverse effects (P-gp-mediated transport possibly inhibited)

  • ertugliflozin
  • Inpefa (sotagliflozin)
    +
    ertugliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + ertugliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • lofexidine
  • Inpefa (sotagliflozin)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • neratinib
  • Inpefa (sotagliflozin)
    +
    neratinib
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + neratinib

    avoid combo if also combined w/ mod-strong CYP3A4 inhibitor; otherwise, caution advised: combo may incr. neratinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • pralsetinib
  • Inpefa (sotagliflozin)
    +
    pralsetinib
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + pralsetinib

    use alternative or consider monitoring ECG, electrolytes and decr. pralsetinib dose as follows: if on pralsetinib 400 mg qd, decr. to 300 mg qd; if on pralsetinib 400 mg qd and also combined w/ strong CYP3A4 inhibitor: decr. to 200 mg qd; if on pralsetinib 300 mg qd, decr. to 200 mg qd; if on pralsetinib 200 mg qd, decr. to 100 mg qd: combo may incr. pralsetinib levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (P-gp-mediated transport inhibited)

  • relugolix
  • Inpefa (sotagliflozin)
    +
    relugolix
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + relugolix

    PROSTATE CANCER: may hold relugolix if sotagliflozin tx up to 2wk; otherwise, use alternative or monitor ECG, electrolytes and admin. relugolix at least 6h before sotagliflozin; FIBROID-ASSOC. BLEEDING: use alternative or admin. relugolix at least 6h before sotagliflozin: combo may incr. relugolix levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (gut P-gp-mediated transport inhibited)

  • repotrectinib
  • Inpefa (sotagliflozin)
    +
    repotrectinib
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + repotrectinib

    avoid combo: combo may incr. repotrectinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • rivaroxaban
  • Inpefa (sotagliflozin)
    +
    rivaroxaban
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + rivaroxaban

    avoid combo if also combined w/ strong CYP3A4 inhibitor; use alternative if CrCl <80 and combined w/ moderate CYP3A4 inhibitor; otherwise, monitor bleeding s/sx: combo may incr. rivaroxaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • sirolimus albumin-bound
  • Inpefa (sotagliflozin)
    +
    sirolimus albumin-bound
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + sirolimus albumin-bound

    avoid combo: combo may incr. sirolimus albumin-bound levels, risk of serious infection, myelosuppression, bleeding (including life-threatening), other adverse effects (P-gp-mediated transport inhibited)

  • sotagliflozin
  • Inpefa (sotagliflozin)
    +
    sotagliflozin
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + sotagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • topotecan
  • Inpefa (sotagliflozin)
    +
    topotecan
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + topotecan

    avoid combo w/ oral topotecan: combo may incr. topotecan levels, risk of serious infection, myelosuppression, other adverse effects (gut P-gp-mediated transport inhibited)

  • venetoclax
  • Inpefa (sotagliflozin)
    +
    venetoclax
    1 interaction

    Avoid/Use Alternative

    sotagliflozin + venetoclax

    monitor CBC, tumor lysis syndrome s/sx; CLL/SLL: consider alternative or decr. venetoclax dose by at least 50%; AML: decr. venetoclax dose by at least 50%: combo may incr. venetoclax levels, risk of serious infection, myelosuppression, tumor lysis syndrome, other adverse effects (P-gp-mediated transport inhibited)

Monitor/Modify Tx

  • acebutolol
  • Inpefa (sotagliflozin)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • afatinib
  • Inpefa (sotagliflozin)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + afatinib

    decr. afatinib dose by 10 mg/day if not tolerated: combo may incr. afatinib levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • alfentanil
  • Inpefa (sotagliflozin)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Inpefa (sotagliflozin)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Inpefa (sotagliflozin)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • alogliptin
  • Inpefa (sotagliflozin)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + alogliptin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • alprostadil intracavernous
  • Inpefa (sotagliflozin)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

  • amantadine
  • Inpefa (sotagliflozin)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Inpefa (sotagliflozin)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including syncope (additive effects)

  • amiloride
  • Inpefa (sotagliflozin)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amitriptyline
  • Inpefa (sotagliflozin)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Inpefa (sotagliflozin)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Inpefa (sotagliflozin)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • apomorphine
  • Inpefa (sotagliflozin)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + apomorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Inpefa (sotagliflozin)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aprocitentan
  • Inpefa (sotagliflozin)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole bimonthly injection
  • Inpefa (sotagliflozin)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aripiprazole bimonthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aripiprazole lauroxil
  • Inpefa (sotagliflozin)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aripiprazole lauroxil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole monthly injection
  • Inpefa (sotagliflozin)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aripiprazole monthly injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole oral
  • Inpefa (sotagliflozin)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + aripiprazole oral

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • articaine
  • Inpefa (sotagliflozin)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • asenapine
  • Inpefa (sotagliflozin)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + asenapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • atenolol
  • Inpefa (sotagliflozin)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • atorvastatin
  • Inpefa (sotagliflozin)
    +
    atorvastatin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + atorvastatin

    monitor CK, myopathy sx: combo may incr. atorvastatin levels, risk of myopathy, rhabdomyolysis, other adverse effects (P-gp-mediated transport inhibited)

  • avanafil
  • Inpefa (sotagliflozin)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Inpefa (sotagliflozin)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • benazepril
  • Inpefa (sotagliflozin)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + benazepril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • berberine
  • Inpefa (sotagliflozin)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol
  • Inpefa (sotagliflozin)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Inpefa (sotagliflozin)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bethanechol
  • Inpefa (sotagliflozin)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bisoprolol
  • Inpefa (sotagliflozin)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Inpefa (sotagliflozin)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • brexpiprazole
  • Inpefa (sotagliflozin)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + brexpiprazole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • brimonidine ophthalmic
  • Inpefa (sotagliflozin)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • brimonidine topical
  • Inpefa (sotagliflozin)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Inpefa (sotagliflozin)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of hypoglycemia, hypotension, including orthostasis, syncope (additive effects)

  • bumetanide
  • Inpefa (sotagliflozin)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bumetanide

    monitor BP, electrolytes, volume status, renal fxn: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects (additive effects)

  • bupivacaine
  • Inpefa (sotagliflozin)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine liposomal
  • Inpefa (sotagliflozin)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • buprenorphine
  • Inpefa (sotagliflozin)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Inpefa (sotagliflozin)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + butorphanol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Inpefa (sotagliflozin)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • candesartan cilexetil
  • Inpefa (sotagliflozin)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cannabis
  • Inpefa (sotagliflozin)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + cannabis

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • captopril
  • Inpefa (sotagliflozin)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cariprazine
  • Inpefa (sotagliflozin)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + cariprazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carteolol ophthalmic
  • Inpefa (sotagliflozin)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carvedilol
  • Inpefa (sotagliflozin)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + carvedilol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chloroprocaine
  • Inpefa (sotagliflozin)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorothiazide
  • Inpefa (sotagliflozin)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + chlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chlorpromazine
  • Inpefa (sotagliflozin)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Inpefa (sotagliflozin)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + chlorthalidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cilostazol
  • Inpefa (sotagliflozin)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clevidipine
  • Inpefa (sotagliflozin)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clofarabine
  • Inpefa (sotagliflozin)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • clomipramine
  • Inpefa (sotagliflozin)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clonidine
  • Inpefa (sotagliflozin)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Inpefa (sotagliflozin)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + clozapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • codeine
  • Inpefa (sotagliflozin)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Inpefa (sotagliflozin)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • colesevelam
  • Inpefa (sotagliflozin)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may incr. risk of hypoglycemia (additive effects)

  • cyclosporine
  • Inpefa (sotagliflozin)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + cyclosporine

    monitor cyclosporine levels, renal fxn: combo may incr. cyclosporine levels, risk of serious infection, nephrotoxicity, other adverse effects (P-gp-mediated transport inhibited)

  • denileukin diftitox
  • Inpefa (sotagliflozin)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Inpefa (sotagliflozin)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + desflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desipramine
  • Inpefa (sotagliflozin)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dexmedetomidine
  • Inpefa (sotagliflozin)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Inpefa (sotagliflozin)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • digoxin
  • Inpefa (sotagliflozin)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + digoxin

    monitor digoxin levels, HR; decr. digoxin frequency or dose by 15-30%: combo may incr. digoxin levels, risk of bradycardia, AV block, other adverse effects (P-gp-mediated transport inhibited)

  • dihydrocodeine
  • Inpefa (sotagliflozin)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Inpefa (sotagliflozin)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dinutuximab
  • Inpefa (sotagliflozin)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • dipyridamole
  • Inpefa (sotagliflozin)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • doxazosin
  • Inpefa (sotagliflozin)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Inpefa (sotagliflozin)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Inpefa (sotagliflozin)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + dronabinol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • duloxetine
  • Inpefa (sotagliflozin)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • edoxaban
  • Inpefa (sotagliflozin)
    +
    edoxaban
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + edoxaban

    monitor bleeding s/sx: combo may incr. edoxaban levels, risk of bleeding, other adverse effects (P-gp-mediated transport inhibited)

  • enalapril
  • Inpefa (sotagliflozin)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalaprilat
  • Inpefa (sotagliflozin)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enfortumab vedotin
  • Inpefa (sotagliflozin)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + enfortumab vedotin

    if also combined w/ strong CYP3A4 inhibitor, monitor CBC, glucose: combo may incr. enfortumab vedotin levels, risk of myelosuppression, neuropathy, hyperglycemia, other adverse effects (P-gp-mediated transport inhibited)

  • entacapone
  • Inpefa (sotagliflozin)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Inpefa (sotagliflozin)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + entrectinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • eplerenone
  • Inpefa (sotagliflozin)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • epoprostenol
  • Inpefa (sotagliflozin)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • esmolol
  • Inpefa (sotagliflozin)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ethacrynic acid
  • Inpefa (sotagliflozin)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ethacrynic acid

    monitor BP, electrolytes, volume status, renal fxn: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects (additive effects)

  • ethanol (alcoholic beverage)
  • Inpefa (sotagliflozin)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethanol injection
  • Inpefa (sotagliflozin)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • etripamil nasal
  • Inpefa (sotagliflozin)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • everolimus
  • Inpefa (sotagliflozin)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + everolimus

    TSC-ASSOC. SEGA, TSC-ASSOC. PARTIAL ONSET SEIZURES, TRANSPLANT: monitor everolimus levels, CBC; OTHER INDICATIONS: monitor CBC: combo may incr. everolimus levels, risk of myelosuppression, other adverse effects (P-gp-mediated transport inhibited)

  • exenatide
  • Inpefa (sotagliflozin)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + exenatide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • felodipine
  • Inpefa (sotagliflozin)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenoldopam
  • Inpefa (sotagliflozin)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fentanyl
  • Inpefa (sotagliflozin)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Inpefa (sotagliflozin)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flaxseed
  • Inpefa (sotagliflozin)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flibanserin
  • Inpefa (sotagliflozin)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • fluphenazine
  • Inpefa (sotagliflozin)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fosinopril
  • Inpefa (sotagliflozin)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • foslevodopa
  • Inpefa (sotagliflozin)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • furosemide
  • Inpefa (sotagliflozin)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + furosemide

    monitor BP, electrolytes, volume status, renal fxn: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects (additive effects)

  • garlic
  • Inpefa (sotagliflozin)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gilteritinib
  • Inpefa (sotagliflozin)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • glimepiride
  • Inpefa (sotagliflozin)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + glimepiride

    monitor glucose; consider decr. glimepiride dose: combo may incr. risk of hypoglycemia (additive effects)

  • glipizide
  • Inpefa (sotagliflozin)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + glipizide

    monitor glucose; consider decr. glipizide dose: combo may incr. risk of hypoglycemia (additive effects)

  • glyburide
  • Inpefa (sotagliflozin)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + glyburide

    monitor glucose; consider decr. glyburide dose: combo may incr. risk of hypoglycemia (additive effects)

  • guanfacine
  • Inpefa (sotagliflozin)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • haloperidol
  • Inpefa (sotagliflozin)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydralazine
  • Inpefa (sotagliflozin)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrochlorothiazide
  • Inpefa (sotagliflozin)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrocodone
  • Inpefa (sotagliflozin)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydromorphone
  • Inpefa (sotagliflozin)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • iloperidone
  • Inpefa (sotagliflozin)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + iloperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iloprost
  • Inpefa (sotagliflozin)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Inpefa (sotagliflozin)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • indapamide
  • Inpefa (sotagliflozin)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • insulin
  • Inpefa (sotagliflozin)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + insulin

    monitor glucose; consider decr. insulin dose: combo may incr. risk of hypoglycemia (additive effects)

  • irbesartan
  • Inpefa (sotagliflozin)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • iron sucrose
  • Inpefa (sotagliflozin)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isocarboxazid
  • Inpefa (sotagliflozin)
    +
    isocarboxazid
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + isocarboxazid

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoflurane
  • Inpefa (sotagliflozin)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + isoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isosorbide dinitrate
  • Inpefa (sotagliflozin)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Inpefa (sotagliflozin)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Inpefa (sotagliflozin)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • labetalol
  • Inpefa (sotagliflozin)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • landiolol
  • Inpefa (sotagliflozin)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levobunolol ophthalmic
  • Inpefa (sotagliflozin)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levodopa
  • Inpefa (sotagliflozin)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levorphanol
  • Inpefa (sotagliflozin)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Inpefa (sotagliflozin)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • linagliptin
  • Inpefa (sotagliflozin)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + linagliptin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • liraglutide
  • Inpefa (sotagliflozin)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + liraglutide

    monitor glucose in type 2 diabetes mellitus pts, consider monitoring glucose in obesity pts: combo may incr. risk of hypoglycemia (additive effects)

  • lisinopril
  • Inpefa (sotagliflozin)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lisinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lithium
  • Inpefa (sotagliflozin)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lithium

    monitor lithium levels: combo may decr. lithium levels, efficacy (lithium renal excretion possibly altered)

  • lixisenatide
  • Inpefa (sotagliflozin)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lixisenatide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • losartan
  • Inpefa (sotagliflozin)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • loxapine
  • Inpefa (sotagliflozin)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Inpefa (sotagliflozin)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lumateperone
  • Inpefa (sotagliflozin)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lumateperone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lurasidone
  • Inpefa (sotagliflozin)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + lurasidone

    monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • magnesium sulfate
  • Inpefa (sotagliflozin)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • maraviroc
  • Inpefa (sotagliflozin)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mavorixafor
  • Inpefa (sotagliflozin)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + mavorixafor

    monitor ECG: combo may incr. mavorixafor levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (P-gp-mediated transport inhibited)

  • meperidine
  • Inpefa (sotagliflozin)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Inpefa (sotagliflozin)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methadone
  • Inpefa (sotagliflozin)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Inpefa (sotagliflozin)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methyldopa
  • Inpefa (sotagliflozin)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + methyldopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Inpefa (sotagliflozin)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metolazone
  • Inpefa (sotagliflozin)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + metolazone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metoprolol
  • Inpefa (sotagliflozin)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • midazolam
  • Inpefa (sotagliflozin)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milrinone
  • Inpefa (sotagliflozin)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milsaperidone
  • Inpefa (sotagliflozin)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + milsaperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Inpefa (sotagliflozin)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirtazapine
  • Inpefa (sotagliflozin)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • moexipril
  • Inpefa (sotagliflozin)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • molindone
  • Inpefa (sotagliflozin)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • morphine
  • Inpefa (sotagliflozin)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + morphine

    monitor respiratory rate, BP, consider decr. dose of one or both drugs: combo may incr. morphine levels, risk of CNS and respiratory depression, psychomotor impairment, severe hypotension (including orthostasis, syncope), other adverse effects (P-gp-mediated transport inhibited, additive effects)

  • nadolol
  • Inpefa (sotagliflozin)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nadolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nalbuphine
  • Inpefa (sotagliflozin)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Inpefa (sotagliflozin)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nateglinide

    monitor glucose; consider decr. nateglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • nattokinase
  • Inpefa (sotagliflozin)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • naxitamab
  • Inpefa (sotagliflozin)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Inpefa (sotagliflozin)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • niacin (vitamin B3)
  • Inpefa (sotagliflozin)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nicardipine
  • Inpefa (sotagliflozin)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Inpefa (sotagliflozin)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Inpefa (sotagliflozin)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nisoldipine
  • Inpefa (sotagliflozin)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Inpefa (sotagliflozin)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitrite
  • Inpefa (sotagliflozin)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Inpefa (sotagliflozin)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Inpefa (sotagliflozin)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • nortriptyline
  • Inpefa (sotagliflozin)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Inpefa (sotagliflozin)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • olanzapine
  • Inpefa (sotagliflozin)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + olanzapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Inpefa (sotagliflozin)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Inpefa (sotagliflozin)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • opicapone
  • Inpefa (sotagliflozin)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Inpefa (sotagliflozin)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Inpefa (sotagliflozin)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + oxazepam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oxycodone
  • Inpefa (sotagliflozin)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Inpefa (sotagliflozin)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • paliperidone
  • Inpefa (sotagliflozin)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + paliperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • palopegteriparatide
  • Inpefa (sotagliflozin)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pentamidine
  • Inpefa (sotagliflozin)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • pentazocine
  • Inpefa (sotagliflozin)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Inpefa (sotagliflozin)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perindopril
  • Inpefa (sotagliflozin)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perphenazine
  • Inpefa (sotagliflozin)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • phenelzine
  • Inpefa (sotagliflozin)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + phenelzine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Inpefa (sotagliflozin)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Inpefa (sotagliflozin)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentolamine
  • Inpefa (sotagliflozin)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pindolol
  • Inpefa (sotagliflozin)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pindolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pioglitazone
  • Inpefa (sotagliflozin)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pioglitazone

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • pramipexole
  • Inpefa (sotagliflozin)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Inpefa (sotagliflozin)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + pramlintide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • prazosin
  • Inpefa (sotagliflozin)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • procarbazine
  • Inpefa (sotagliflozin)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + procarbazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • prochlorperazine
  • Inpefa (sotagliflozin)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Inpefa (sotagliflozin)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + promethazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propafenone
  • Inpefa (sotagliflozin)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propofol
  • Inpefa (sotagliflozin)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + propofol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • propranolol
  • Inpefa (sotagliflozin)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • protriptyline
  • Inpefa (sotagliflozin)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quetiapine
  • Inpefa (sotagliflozin)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + quetiapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • quinapril
  • Inpefa (sotagliflozin)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quinidine (antiarrhythmic)
  • Inpefa (sotagliflozin)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + quinidine (antiarrhythmic)

    monitor quinidine levels, ECG: combo may incr. quinidine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (P-gp-mediated transport inhibited)

  • ramipril
  • Inpefa (sotagliflozin)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ranolazine
  • Inpefa (sotagliflozin)
    +
    ranolazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ranolazine

    monitor ECG: combo may incr. ranolazine levels, risk of QT prolongation, cardiac arrhythmias, other adverse effects (P-gp-mediated transport inhibited)

  • rasagiline
  • Inpefa (sotagliflozin)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • remifentanil
  • Inpefa (sotagliflozin)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Inpefa (sotagliflozin)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + remimazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • repaglinide
  • Inpefa (sotagliflozin)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + repaglinide

    monitor glucose; consider decr. repaglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • riociguat
  • Inpefa (sotagliflozin)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • risperidone
  • Inpefa (sotagliflozin)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + risperidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ropinirole
  • Inpefa (sotagliflozin)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ropinirole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Inpefa (sotagliflozin)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rosiglitazone
  • Inpefa (sotagliflozin)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + rosiglitazone

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • rotigotine transdermal
  • Inpefa (sotagliflozin)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + rotigotine transdermal

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Inpefa (sotagliflozin)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Inpefa (sotagliflozin)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • saxagliptin
  • Inpefa (sotagliflozin)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + saxagliptin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • selegiline
  • Inpefa (sotagliflozin)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Inpefa (sotagliflozin)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • semaglutide
  • Inpefa (sotagliflozin)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + semaglutide

    monitor glucose in type 2 diabetes mellitus pts; consider monitoring glucose in obesity pts: combo may incr. risk of hypoglycemia (additive effects)

  • sevoflurane
  • Inpefa (sotagliflozin)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sevoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sildenafil
  • Inpefa (sotagliflozin)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • silodosin
  • Inpefa (sotagliflozin)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sirolimus
  • Inpefa (sotagliflozin)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sirolimus

    monitor sirolimus levels: combo may incr. sirolimus levels, risk of serious infection, other adverse effects (P-gp-mediated transport inhibited)

  • sitagliptin
  • Inpefa (sotagliflozin)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sitagliptin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • sodium ferric gluconate complex
  • Inpefa (sotagliflozin)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sotalol
  • Inpefa (sotagliflozin)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sotalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sparsentan
  • Inpefa (sotagliflozin)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Inpefa (sotagliflozin)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + spironolactone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sufentanil
  • Inpefa (sotagliflozin)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • tacrolimus
  • Inpefa (sotagliflozin)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tacrolimus

    monitor tacrolimus levels, ECG, renal fxn: combo may incr. tacrolimus levels, risk of QT prolongation, cardiac arrhythmias, nephrotoxicity, other adverse effects (P-gp-mediated transport inhibited)

  • tadalafil
  • Inpefa (sotagliflozin)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tagraxofusp
  • Inpefa (sotagliflozin)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • talazoparib
  • Inpefa (sotagliflozin)
    +
    talazoparib
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + talazoparib

    monitor CBC: combo may incr. talazoparib levels, risk of myelosuppression, other adverse effects (P-gp-mediated transport inhibited)

  • tamsulosin
  • Inpefa (sotagliflozin)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Inpefa (sotagliflozin)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Inpefa (sotagliflozin)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • telmisartan
  • Inpefa (sotagliflozin)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + telmisartan

    monitor BP: combo may decr. sotagliflozin levels, efficacy; may incr. risk of hypotension, including orthostasis (UGT induced; additive effects)

  • tenofovir alafenamide
  • Inpefa (sotagliflozin)
    +
    tenofovir alafenamide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tenofovir alafenamide

    if tenofovir alafenamide not admin. w/ cobicistat, monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited)

  • tenofovir disoproxil
  • Inpefa (sotagliflozin)
    +
    tenofovir disoproxil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tenofovir disoproxil

    monitor renal fxn: combo may incr. tenofovir levels, risk of nephrotoxicity, other adverse effects (gut P-gp-mediated transport inhibited)

  • terazosin
  • Inpefa (sotagliflozin)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • thalidomide
  • Inpefa (sotagliflozin)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Inpefa (sotagliflozin)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Inpefa (sotagliflozin)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + thiothixene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • timolol
  • Inpefa (sotagliflozin)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • timolol ophthalmic
  • Inpefa (sotagliflozin)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tizanidine
  • Inpefa (sotagliflozin)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Inpefa (sotagliflozin)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Inpefa (sotagliflozin)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + torsemide

    monitor BP, electrolytes, volume status, renal fxn: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects (additive effects)

  • tramadol
  • Inpefa (sotagliflozin)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tramadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Inpefa (sotagliflozin)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + trandolapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tranylcypromine
  • Inpefa (sotagliflozin)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + tranylcypromine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trazodone
  • Inpefa (sotagliflozin)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Inpefa (sotagliflozin)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamterene
  • Inpefa (sotagliflozin)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + triamterene

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • trifluoperazine
  • Inpefa (sotagliflozin)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Inpefa (sotagliflozin)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ubrogepant
  • Inpefa (sotagliflozin)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ubrogepant

    limit ubrogepant dose to 50 mg, may give second 50 mg dose after 2h if needed: combo may incr. ubrogepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • valsartan
  • Inpefa (sotagliflozin)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vardenafil
  • Inpefa (sotagliflozin)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • verapamil
  • Inpefa (sotagliflozin)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vosoritide
  • Inpefa (sotagliflozin)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • yohimbe
  • Inpefa (sotagliflozin)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ziprasidone
  • Inpefa (sotagliflozin)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    sotagliflozin + ziprasidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

Caution Advised

  • darolutamide
  • Inpefa (sotagliflozin)
    +
    darolutamide
    1 interaction

    Caution Advised

    sotagliflozin + darolutamide

    if also combined w/ strong CYP3A4 inhibitor, caution advised: combo may incr. darolutamide levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • fexinidazole
  • Inpefa (sotagliflozin)
    +
    fexinidazole
    1 interaction

    Caution Advised

    sotagliflozin + fexinidazole

    caution advised: combo may decr. sotagliflozin levels, efficacy (UGT possibly induced)

  • glecaprevir
  • Inpefa (sotagliflozin)
    +
    glecaprevir
    1 interaction

    Caution Advised

    sotagliflozin + glecaprevir

    caution advised: combo may incr. glecaprevir levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • naldemedine
  • Inpefa (sotagliflozin)
    +
    naldemedine
    1 interaction

    Caution Advised

    sotagliflozin + naldemedine

    caution advised: combo may incr. naldemedine levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • nevirapine
  • Inpefa (sotagliflozin)
    +
    nevirapine
    1 interaction

    Caution Advised

    sotagliflozin + nevirapine

    caution advised: combo may decr. sotagliflozin levels, efficacy (UGT induced)

  • pibrentasvir
  • Inpefa (sotagliflozin)
    +
    pibrentasvir
    1 interaction

    Caution Advised

    sotagliflozin + pibrentasvir

    caution advised: combo may incr. pibrentasvir levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • rifampin
  • Inpefa (sotagliflozin)
    +
    rifampin
    1 interaction

    Caution Advised

    sotagliflozin + rifampin

    caution advised: combo may decr. sotagliflozin levels, efficacy (UGT induced)

  • ritonavir
  • Inpefa (sotagliflozin)
    +
    ritonavir
    1 interaction

    Caution Advised

    sotagliflozin + ritonavir

    caution advised: combo may decr. sotagliflozin levels, efficacy (UGT induced)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@42724deb
  • acute kidney injury
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • Fournier gangrene
  • hypotension

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@2ea1d467
  • UTI
  • volume depletion
  • diarrhea
  • hypoglycemia
  • dizziness
  • genital mycotic infection

Safety/Monitoring .

Monitoring Parameters
volume status at baseline; eGFR at baseline, then as clinically indicated; BP

Pregnancy/Lactation .

Pregnancy

Clinical Summary

avoid use in 2nd and 3rd trimester, weigh risk/benefit in 1st trimester; inadequate human data available; risk of adverse effects on renal development and maturation in 2nd and 3rd trimesters based on animal data at 5x MRHD and drug's mechanism of action; no known risk of teratogenicity in 1st trimester based on animal data at up to 40x MRHD; risk of teratogenicity and fetal abnormalities in 1st trimester based on animal data at 161x MRHD

Lactation

Clinical Summary

avoid use while breastfeeding; no human data available, though possible risk of adverse effects on infant renal development and maturation based on drug's mechanism of action; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@2089fd

Metabolism: for sotagliflozin: glucuronidation; CYP: 3A4 substrate; UGT: 1A9 (primary) substrate

Excretion: for sotagliflozin: urine 57%, feces 37% (primarily unchanged); Half-life: 5-10h

Subclass: SGLT1 Inhibitors, Cardiovascular ; SGLT2 Inhibitors, Cardiovascular

Mechanism of Action
for sotagliflozin: inhibits sodium-glucose cotransporter 1 (SGLT1), reducing glucose and sodium intestinal absorption; inhibits sodium-glucose cotransporter 2 (SGLT2), reducing glucose and sodium renal reabsorption; may reduce cardiac preload and afterload and downregulate sympathetic activity

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Lexicon Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@25d37cec

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information